EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Ketamine or ECT? What Have We Learned From the KetECT and ELEKT-D Trials?

Joakim Ekstrand, Akihiro Takamiya iD, Axel Nordenskjold iD, George Kirov iD, Pascal Sienaert iD, Charles H Kellner iD, Pouya Movahed Rad iD

International Journal of Neuropsychopharmacology · 2024

DOI: 10.1093/ijnp/pyad065 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Neuropsychopharmacology, 2024. Verfasst von Joakim Ekstrand und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Sciences, Division of Adult Psychiatry Faculty of Medicine, Lund University, Lund, Sweden. Hauptthemen laut MEDLINE: Ketamine, Electroconvulsive Therapy, Major Depressive Disorder. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

1. Two recent clinical trials, KetECT and ELEKT-D, compared the effectiveness of ketamine and electroconvulsive therapy (ECT) for major depressive disorder. Notably, these trials reported marked differences in ECT's clinical outcomes of, with remission rates of 63% for KetECT and a strikingly lower rate of 22% for ELEKT-D, while the remission rates for ketamine were 46% and 38%, respectively. Considering that the primary objective of both trials was to compare the standard treatment (ECT) with an experimental intervention (ketamine), it is crucial to highlight the pronounced disparities in ECT’s clinical outcomes. This article offers a comprehensive comparison of these trials while also exploring how patient characteristics, treatment protocols, and study designs may contribute to such pronounced outcome discrepancies. These differences highlight the heterogeneous nature of depression and underscore the need for personalized treatments. These studies also provide valuable insights into identifying the most suitable candidates for ketamine and ECT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

KetamineElectroconvulsive TherapyMajor Depressive DisorderHumansLearningResearch DesignTreatment Outcome

Stichwörter der Autor:innen

Major depressive disorderclinical trialselectroconvulsive therapyracemic ketamine

Substanzen

Ketamine

Autor:innen und Institutionen

  • Department of Clinical Sciences, Division of Adult Psychiatry Faculty of Medicine, Lund University, Lund, Sweden.
  • KU Leuven, Leuven Brain Institute, Department of Neurosciences, Neuropsychiatry, Leuven, Belgium.
  • Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan. Hills Joint Research Laboratory for Future Preventive Medicine and Wellness, Keio University School of Medicine, Tokyo, Japan.
  • University Health Care Research Centre, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
  • Centre for Neuropsychiatric Genetics and Genomics, Cardiff University School of Medicine, Division of Psychological Medicine and Clinical Neuroscience, Cardiff, UK.
  • Department of Neurosciences, University Psychiatric Center KU Leuven, Research Group Psychiatry, Academic Center for ECT and Neuromodulation (AcCENT), KU Leuven, Leuven, Belgium.

ORCID-Profile: Akihiro Takamiya, Axel Nordenskjold, George Kirov, Pascal Sienaert, Charles H Kellner, Pouya Movahed Rad

Zitieren

APA

Ekstrand, J., Takamiya, A., Nordenskjold, A., Kirov, G., Sienaert, P., Kellner, C. H., & Movahed Rad, P. (2024). Ketamine or ECT? What Have We Learned From the KetECT and ELEKT-D Trials?. International Journal of Neuropsychopharmacology. https://doi.org/10.1093/ijnp/pyad065

Vancouver

Ekstrand J, Takamiya A, Nordenskjold A, Kirov G, Sienaert P, Kellner CH, et al. Ketamine or ECT? What Have We Learned From the KetECT and ELEKT-D Trials?. International Journal of Neuropsychopharmacology. 2024. doi:10.1093/ijnp/pyad065

BibTeX
@article{Ekstrand2024,
  author = {Ekstrand, Joakim and Takamiya, Akihiro and Nordenskjold, Axel and Kirov, George and Sienaert, Pascal and Kellner, Charles H and Movahed Rad, Pouya},
  title = {Ketamine or ECT? What Have We Learned From the KetECT and ELEKT-D Trials?},
  journal = {International Journal of Neuropsychopharmacology},
  year = {2024},
  doi = {10.1093/ijnp/pyad065}
}
Kostenlos starten →